Covestor LTD Ligand Pharmaceuticals Inc Transaction History

Covestor LTD

$160 Million
Q3 2024

A detailed history of Covestor LTD transactions in Ligand Pharmaceuticals Inc stock. As of the latest transaction made, Covestor LTD holds 5 shares of LGND stock, worth $595. This represents 0.0% of its overall portfolio holdings.

Number of Shares

Previous 13 61.54%

Holding current value

$595

Previous $1,000 -0.0%

% of portfolio

0.0%

Previous 0.0%

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 01, 2024	SELL	$82.7 - $110.11 $661 - $880	-8 Reduced 61.54%	5 $1,000
Q1 2024 May 10, 2024	BUY	$68.64 - $89.2 $480 - $624	7 Added 116.67%	13 $1,000
Q4 2023 Feb 09, 2024	BUY	$49.57 - $72.63 $49 - $72	1 Added 20.0%	6 $0
Q3 2023 Nov 13, 2023	BUY	$58.86 - $72.67 $117 - $145	2 Added 66.67%	5 $0
Q1 2023 May 15, 2023	BUY	$65.67 - $77.08 $65 - $77	1 Added 50.0%	3 $0
Q3 2022 Nov 14, 2022	SELL	$0.01 - $107.56 $0 - $107	-1 Reduced 33.33%	2 $0
Q1 2022 May 13, 2022	SELL	$94.99 - $151.56 $189 - $303	-2 Reduced 40.0%	3 $0
Q4 2021 Feb 10, 2022	BUY	$127.69 - $165.85 $638 - $829	5 New	5 $1,000

Others Institutions Holding LGND

# of Institutions

257

Shares Held

18.2M

Call Options Held

26.8K

Put Options Held

9.3K

View Full List

About LIGAND PHARMACEUTICALS INC

Ticker LGND
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,882,800
Market Cap $2.01B
Description
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...

More about LGND

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Covestor LTD, based on Form 13F filings with the SEC.

News

Stay updated on Covestor LTD with notifications on news.

Account